Skip to main content
. 2024 May 3;12(5):494. doi: 10.3390/vaccines12050494

Figure 2.

Figure 2

Forest plot of pooled mean anti-RBD antibody titer among subjects who did not acquire breakthrough SARS-CoV-2 infection [18,22,32].